News
Revenue reached $1.67 billion in Q1, up modestly from $1.66 billion a year earlier, with higher-than-expected engagement seen ...
The online travel giant reported earnings of $55.40 per share, beating the consensus estimate of $50.14. Revenue rose 17% ...
Avis Budget Group ended the quarter with net income of $5 million and Adjusted EBITDA of $277 million. The company’s Americas ...
Investing.com - Canada’s main stock exchange rose on Tuesday, as investors digested a raft of corporate returns, looked ahead ...
Separately, Whirlpool proposed cutting its annual dividend to $3.60 from $7.00 and lowered its 2025 free cash flow guidance ...
Investing.com -- United Airlines flight attendants voted to reject a tentative agreement for a new contract with the carrier ...
Investing.com -- Apple Inc (NASDAQ: AAPL ). has lost another key artificial intelligence researcher to Meta Platforms (NASDAQ ...
Investing.com -- Cardiff Oncology Inc (NASDAQ: CRDF) reported second-quarter earnings that missed analyst expectations, sending shares tumbling 22% as investors reacted to the wider-than-expected loss ...
The footwear manufacturer posted adjusted earnings of $0.55 per diluted share for the quarter ended June 30, 2025, more than double the analyst estimate of $0.25. Revenue climbed 7.5% YoY to $105.6 ...
Ryerson Holding Corporation (NYSE: RYI), a metals processor and distributor, reported second-quarter earnings that fell short of analyst expectations as the compa ...
BlueLinx’s performance was hampered by challenging market conditions despite volume increases in both specialty and structural products. Gross profit declined 2% YoY to $120 million, with gross margin ...
Investing.com -- Aclaris Therapeutics Inc (NASDAQ: ACRS) stock surged 20% in after-hours trading following the announcement of positive top-line results from its Phase 2a trial of ATI-2138 in patients ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results